Investigations

1st investigations to order

DNA-based assays

Test
Result
Test

Highly accurate; often used for confirming an abnormality found by haemoglobin studies. May be used in place of haemoglobin studies in some screening programmes.[25][26][27][28]

Result

replacement of both beta haemoglobin subunits with HbS is diagnostic for sickle cell anaemia (HbSS); presence of 1 normal beta haemoglobin subunit and 1 HbS is diagnostic for sickle cell trait

haemoglobin isoelectric focusing (Hb IEF)

Test
Result
Test

Newborn screening is typically performed using Hb IEF or high-performance liquid chromatography (HPLC) fractionation. Confirmatory testing should be performed by an alternative method (IEF, HPLC, electrophoresis, or DNA sequencing).[25]

Result

fetal haemoglobin (HbF) will predominate in newborns with sickle cell disease; in older infants the amount of HbS will increase as HbF decreases; by 2 years of age the amount of HbS and HbF stabilises; patients with sickle cell anaemia will have no HbA

cellulose acetate electrophoresis

Test
Result
Test

In older children and adults, cellulose acetate electrophoresis at an alkaline pH is most commonly used to determine haemoglobin subtype. Diagnosis can be confirmed using an alternative method.

Result

sickle cell anaemia 75% to 95% HbS, HbA is notably absent; sickle cell trait 40% HbS, <2% HbF, 60% HbA

high-performance liquid chromatography (HPLC)

Test
Result
Test

Newborn screening is typically performed using haemoglobin isoelectric focusing (Hb IEF) or HPLC fractionation. Confirmatory testing should be performed by an alternative method (IEF, HPLC, electrophoresis, or DNA sequencing).[25]

Result

in newborns with sickle cell disease, fetal HbF will predominate; in older infants, the amount of HbS will increase as HbF decreases; by 2 years of age the amount of HbS and HbF stabilises; patients with sickle cell anaemia will have no HbA

haemoglobin solubility testing

Test
Result
Test

May be used for initial screening in older children and adults, but cannot distinguish between sickle cell trait (heterozygotes) and sickle cell disease (homozygotes).

Not recommended for infants under 6 months because the high proportion of fetal haemoglobin in relation to adult sickle cell haemoglobin in a newborn's blood may affect the results.

A normal result excludes sickle cell disease in patients older than 6 months without symptoms or signs of severe anaemia or very high fetal haemoglobin levels.

Result

≥10% to 15% HbS

peripheral blood smear

Test
Result
Test

Helps rule out additional causes of anaemia but requires expert interpretation and cannot be used to determine whether patient is in vaso-occlusive crisis.[Figure caption and citation for the preceding image starts]: Red cells in sickle cell diseaseFrom the personal collection of Sophie Lanzkron, MD; used with permission [Citation ends].com.bmj.content.model.Caption@3dea0e99

Evaluation of the type and an estimate of the number of white blood cells, red blood cells, and platelets is made to assess if they are normal in morphology and number. Sickle-shaped cells, Howell-Jolly bodies, presence of nucleated red blood cells, and cell fragments can be seen on the blood smear. Oat cells and target cells can be seen in HbSC disease.

Result

presence of nucleated red blood cells, sickle-shaped cells, and Howell-Jolly bodies

FBC and reticulocyte count

Test
Result
Test

Used in testing older children and adults to evaluate number and quality of red blood cells, haemoglobin content, and white blood cell count. Useful in establishing a baseline for on-going evaluation. Widely available, inexpensive, and provides rapid results, but it is not diagnostic.

Patients can present with vaso-occlusive pain and not have any change from baseline in their haemoglobin or reticulocyte count.

White blood cell count can occasionally be overestimated if the count is not corrected for the presence of nucleated red cells, which are often present.

In patients with very low reticulocyte counts <1%, parvovirus infection should be strongly considered.

Result

some degree of anaemia occurs in most patients; reticulocyte count is usually elevated, but may be reduced in aplastic crisis (caused by parvovirus B19 infection in patients with chronic haemolytic disorders) or bone marrow infarction

iron studies

Test
Result
Test

Helps distinguish haemolytic anaemia from iron-deficiency anaemia. Patients who have been transfused in the past will have elevated results.

Result

serum iron, transferrin, ferritin levels, and serum iron-binding capacity are normal or elevated

Investigations to consider

pulse oximetry

Test
Result
Test

Pulse oximetry monitoring is important as early drops in oxygen saturations can suggest the beginning of acute chest syndrome.

Result

shows oxygen desaturations in acute chest syndrome

plain x-rays of long bones

Test
Result
Test

Used to confirm the presence of bone infarction. Most bone infarctions are diagnosed clinically by symptoms (bone pain) and signs (e.g., absence of fever).

Result

infarctions seen by irregular margins or moth-eaten destruction with overlying periosteal new bone formation

bacterial cultures

Test
Result
Test

Bacterial cultures (using blood, sputum, urine, stool, and/or pus) should be obtained in patients with fever and/or those who appear toxic.

Result

bacterial pathogen culture may confirm infection

chest x-ray

Test
Result
Test

Performed if the patient has respiratory symptoms, fever, or chest pain.[Figure caption and citation for the preceding image starts]: Chest x-ray in acute chest syndromeFrom: Davies SC, Oni L. BMJ. 1997 Sep 13;315(7109):656-60 [Citation ends].com.bmj.content.model.Caption@1aa12a89

Result

presence of pulmonary infiltrate(s) may be an indication of acute chest syndrome

Emerging tests

non-invasive prenatal testing (NIPT)

Test
Result
Test

Emerging as a potential antenatal screening test for haemoglobinopathies such as sickle cell disease and thalassaemia.[16]

Result

relative mutation dosage (RMD) of the sickle cell gene in the cell-free fetal DNA may indicate increased risk

Use of this content is subject to our disclaimer